Cargando…
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
The newly emergent Middle East respiratory syndrome coronavirus (MERS-CoV) can cause severe pulmonary disease in humans(1,2), representing the second example of a highly pathogenic coronavirus, the first being SARS-CoV(3). CD26 (also known as dipeptidyl peptidase 4, DPP4) was recently identified as...
Autores principales: | Lu, Guangwen, Hu, Yawei, Wang, Qihui, Qi, Jianxun, Gao, Feng, Li, Yan, Zhang, Yanfang, Zhang, Wei, Yuan, Yuan, Bao, Jinku, Zhang, Buchang, Shi, Yi, Yan, Jinghua, Gao, George F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095341/ https://www.ncbi.nlm.nih.gov/pubmed/23831647 http://dx.doi.org/10.1038/nature12328 |
Ejemplares similares
-
Molecular Basis of Binding between Middle East Respiratory Syndrome Coronavirus and CD26 from Seven Bat Species
por: Yuan, Yuan, et al.
Publicado: (2020) -
Bat Origins of MERS-CoV Supported by Bat Coronavirus HKU4 Usage of Human Receptor CD26
por: Wang, Qihui, et al.
Publicado: (2014) -
Putative Receptor Binding Domain of Bat-Derived Coronavirus
HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding
Motifs
por: Huang, Canping, et al.
Publicado: (2016) -
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
por: Yuan, Yuan, et al.
Publicado: (2017) -
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
por: Li, Yan, et al.
Publicado: (2015)